Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 701–800 of 1,000
Neural Circuitries between the Brain and Peripheral Solid Tumors
Chen, X., Geng, Y., Wei, G., He, D., Lv, J., Wen, W., Xiang, F., Tao, K., & Wu, C. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1779 · Cited by 21
“…monophosphate-protein kinase A signaling pathway in tumor cells, enhancing the expression of VEGF, matrix metalloproteinase 2, and matrix metalloproteinase 9, significantly increasing tumor vascularization, leading to a greater tumor burden and more aggressive ovarian cancer cell growth (63).”
BackgroundHeterotrimeric G protein signaling in cancer cells with regard to metastasis formation
Entschladen, F., Zänker, K. S., & Powe, D. G. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15208 · Cited by 24
The Neural Regulation of Cancer
Gillespie, S. M., & Monje, M. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033349 · Cited by 24
Current Therapies and New Targets to Fight Melanoma: A Promising Role for the β3-Adrenoreceptor
Filippi, L., Bruno, G., Domazetovic, V., Favre, C., & Calvani, M. (2020) · Cancers · doi:10.3390/cancers12061415 · Cited by 20
“On the contrary, β-ARs agonists have been found to enhance in vivo tumor progression and metastasis [32,33,35], confirming the critical involvement of β-ARs in cancer biology.”
BackgroundJi, L., Xu, F., Zhang, J., Song, T., Chen, W., Yin, X., Wang, Q., Chen, X., Li, X., Guo, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19991-y · Cited by 21
He, R., He, Y., Tang, Y., Zhou, H., McLeod, H. L., & Liu, J. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.152 · Cited by 19
Gronowicz, G., Secor, E. R., Flynn, J. R., & Kuhn, L. T. (2016) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(16)60275-3 · Cited by 19
Combined anti-proliferative and anti-angiogenic strategies for cancer
Bar, J., & Onn, A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.5.701 · Cited by 19
“The investigators demonstrated that betaadrenergic activity modulates tumor angiogenesis and tumor growth through induction of cyclic AMP and PKA [75] .”
BackgroundWhy stress is BAD for cancer patients
Nagaraja, A. S., Armaiz-Peña, G. N., Lutgendorf, S. K., & Sood, A. K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67887 · Cited by 18
Self-citationDu, Y., Wang, B., Jiang, X. W., Cao, J., Yu, J., Wang, Y., Wang, X., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.620674 · Cited by 24
“These results are consistent with the previous literature (7, 11), while the detection of expression of key genes targeted by these sEMTlnc in vascular smooth muscle cells also suggested that these EMTlnc may be involved in the formation of tumor neovascularization (39).”
ResultFiala, O., Ostašov, P., Rozsypalová, A., Hora, M., Šorejs, O., Šustr, J., Bendová, B., Trávníček, I., Filipovský, J., Fínek, J., et al. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00829-y · Cited by 18
Fonte, R., Strippoli, S., Garofoli, M., Cormio, G., Serratì, S., Loizzi, V., Fasano, R., Arezzo, F., Volpicella, M., Derakhshani, A., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1178316 · Cited by 18
“microenvironment and for that, stress-activated mechanisms driving cancer could be abrogated by the β-adrenergic antagonists, such as propranolol (Thaker et al., 2006).”
BackgroundEudaimonic well‐being and tumor norepinephrine in patients with epithelial ovarian cancer
Davis, L. Z., Slavich, G. M., Thaker, P. H., Goodheart, M. J., Bender, D., Dahmoush, L., Farley, D. M., Markon, K. E., Penedo, F. J., Lubaroff, D. M., et al. (2015) · Cancer · doi:10.1002/cncr.29516 · Cited by 23
“Data from an orthotopic model of ovarian cancer have indicated that restraint-stressed mice demonstrate elevated tumor NE, along with greater tumor weight and nodules.(54) We have previously reported that patients with ovarian cancer with greater social isolation have higher levels of NE in both tumor and ascites,(55)…”
BackgroundSelf-citationComplementary and Integrative Medicine in Lung Cancer: Questions and Challenges
Frenkel, M. A., Slater, R., Sapire, K. J., & Sierpina, V. S. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0175 · Cited by 18
“61,62 Because most patients are diagnosed with lung cancer in the advanced stage, when the prognosis is poor, the stress and anxiety that these patients experience are quite high.”
In Silico Profiling of Clinical Phenotypes for Human Targets Using Adverse Event Data
Soldatos, T. G., Taglang, G., & Jackson, D. (2018) · Microarrays · doi:10.3390/ht7040037 · Cited by 20
“Using prior knowledge about the association between biobehavioral stress and tumorigenesis [12,13], we investigated whether perturbation of beta-adrenergic receptor (BAR) function in cancer patients might result in lower patient mortality.”
BackgroundImplication of Spiritual Network Support System in Epigenomic Modulation and Health Trajectory
Holmes, L., Chinaka, C., Elmi, H., Deepika, K., Pelaez, L., Enwere, M., Akinola, O., & DABNEY, K. W. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16214123 · Cited by 19
“In effect, social threats or adversity have potential in up-regulating CTRA gene expression in the human immune system, leading to chronic inflammatory response and observed excess malignant neoplasm, diabetes and chronic disease [3,28].”
BackgroundZhao, L., Zhu, X., Ni, Y., You, J., & Li, A. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1839513 · Cited by 21
“Adrenaline and noradrenaline are the most important catecholamine hormones released during stress that may influence cancer progression (Thaker et al. 2006; Eng et al. 2014; Krizanova et al. 2016).”
BackgroundOkhowat, J., Murtinger, M., Schuff, M., Wogatzky, J., Spitzer, D., Vanderzwalmen, P., Wirleitner, B., & Zech, N. H. (2015) · PubMed · Cited by 18
Zhang, D., Lei, J., Ma, J., Chen, X., Sheng, L., Jiang, Z., Nan, L., Xu, Q., Duan, W., Wang, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5677 · Cited by 18
“These findings are in accord with reports on the significant stimulating effects of HIF-1α on the proliferation and metastasis of adenocarcinoma of the PDAC [28, 29], stomach [30], colon, prostate [31], and ovary [13, 14].”
Takahashi, K., Kaira, K., Shimizu, A., Sato, T., Takahashi, N., Ogawa, H., Yoshinari, D., Yokobori, T., Asao, T., Takeyoshi, I., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5139-2 · Cited by 18
“to affect angiogenesis, followed by tumor proliferation and cell growth [5].”
BackgroundA Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience
Arun, B., Austin, T., Babiera, G. V., Basen‐Engquist, K., Carmack, C. L., Chaoul, A., Cohen, L. G., Connelly, L., Haddad, R., Harrison, C. A., et al. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416679516 · Cited by 19
“Sustained elevations from these pathways can result in diverse effects such as inflammation, angiogenesis, stimulation of cancer invasion, and even reduced efficacy of chemotherapy drugs.(30-32) The underlying signaling pathways(33) offer opportunities for designing new biobehavioral approaches for disrupting the effe…”
BackgroundSelf-citationThe Embodiment Dynamic over the Life Course: A Case for Examining Cancer Aetiology
Kelly‐Irving, M., & Delpierre, C. (2017) · Palgrave Macmillan UK eBooks · doi:10.1057/978-1-137-52879-7_22 · Cited by 26
Cuneo, M. G., Szeto, A., Schrepf, A., Kinner, E. M., Schachner, B. I., Ahmed, R., Thaker, P. H., Goodheart, M., Bender, D., Cole, S. W., et al. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.04.007 · Cited by 18
“While these studies are typically examining centrally released oxytocin, relationships between tumor microenvironment oxytocin and psychosocial factors should be investigated as both social isolation and stress have been linked to disease processes in ovarian cancer (Cole and Sood, 2012; Lutgendorf et al., 2012; Lutge…”
BackgroundSelf-citationZhang, Y., Yu, F., Ouyang, J., Liu, P., Dai, Y., Wang, Y., Yi, H., Wang, S., Liu, D., Song, K., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011611 · Cited by 18
Sun, H., Wang, T., Jiang, X., Li, M., He, X., Ma, Y., Li, X., Jin, W., & Jiao, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02412-9 · Cited by 19
“Activation of β₂-AR on endothelial cells induces pathological angiogenesis via the hypoxia-inducible factor (HIF)-1α/VEGF pathway [237, 238].”
Wang, G., & Pan, S. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18313-6 · Cited by 24
“38,39 Our findings suggest that similar pathways may be operative in clinical gastric cancer populations and could be harnessed to support curative-intent therapy.”
Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
Rafiyan, M., Abadi, M. H. J. N., Zadeh, S. S. T., Hamblin, M. R., Mousavi, M., & Mirzaei, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.917471 · Cited by 17
Gümüşoğlu-Acar, E., Günel, T., Hosseini, M. K., Doğan, B., Tekarslan, E. E., Gürdamar, B., Çevik, N., Sezerman, O. U., Topuz, S., & Aydinli, K. (2023) · Oncology Letters · doi:10.3892/ol.2023.13728 · Cited by 18
“CI, confidence interval; miR, microRNA. matrix metalloproteinase‑associated increases in tissue invasion (57,58), VEGF‑mediated increases in angiogen‑ esis (59) and focal adhesion kinase‑mediated resistance to anoikis/apoptosis (60).”
Basarrate, S., Monzel, A. S., Smith, J. L. M., Marsland, A. L., Trumpff, C., & Picard, M. A. (2024) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001275 · Cited by 20
“Stress hormone receptors were selected based on evidence linking specific receptor types to the transduction of psychosocial stress (18-22).”
BackgroundChronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cells
Jürgens, M., Claus, M., Wingert, S., Niemann, J. A., Picard, L. K., Hennes, E., Haasler, I., Hellwig, B., Overbeck, N., Reinders, J., et al. (2024) · European Journal of Immunology · doi:10.1002/eji.202451299 · Cited by 17
Regulska, K., Regulski, M., Karolak, B., Michalak, M., Murias, M., & Stanisz, B. J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104326 · Cited by 17
Neural control of tumor immunity
Kizil, B., Virgiliis, F. D., & Scheiermann, C. (2024) · FEBS Journal · doi:10.1111/febs.17280 · Cited by 17
“Likewise, in mouse models of breast and ovarian cancer, inhibiting sympathetic signaling with b -blockers exerted inhibitory effects on tumor angiogenesis [58,59].”
Cholinergic T cells revitalize the tumor immune microenvironment: TIME to ChAT
Zheng, C., Liu, S., Modares, N. F., Paul, M. S., & Mak, T. W. (2025) · Nature Immunology · doi:10.1038/s41590-025-02144-4 · Cited by 19
“Over the past decade, several landmark reports have shown that the various divisions of the nervous system have active roles in cancer initiation, progression and dissemination 1–3 .”
Ma, Z., Wang, S., Liu, S., Yang, W., Hu, J., Lv, L., Qian, Y., & Lu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653442 · Cited by 18
Chen, Y., Qian, Y., Huang, W., Zhang, Y., Wu, M., Cheng, Y., Yang, N., & Liu, Y. (2022) · PubMed · Cited by 31
Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming
Lu, C., Xu, J., Li, K., Wang, J., Dai, Y., Chen, Y., Chai, R., Xu, C., & Kang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010029 · Cited by 17
“Both epinephrine (E) and norepinephrine (NE) are reported to be increased continuously in patients under chronic stress, and dopamine (DA) levels are decreased [16,17].”
BackgroundSelf-citationImportance of adrenergic pathways in women's cancers
Thaker, P. H., Sood, A. K., & Ramondetta, L. M. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130324 · Cited by 21
“As mentioned previously, in the animal model, increased ovarian tumor vascularization and enhanced expression of VEGF and MMP-2 and -9 in tumor cells of stressed animals could be abrogated by the β -adrenergic antagonist propranolol [20].”
InfluentialSelf-citationZheng, J., Parfett, C. L. J., Williams, A., Yagminas, A. P., Zhou, G., Douglas, G. R., & Yauk, C. L. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2011.02.006 · Cited by 20
Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification
Cho, J.-H., Chun, H.-Y., Lee, J. S., Lee, J.-H., Cheong, K. J., Jung, Y., Woo, T.-G., Yoon, M.-H., Oh, A.-Y., Kang, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9059 · Cited by 16
“Stress hormones can affect various kinds of tissues and cells [13, 24, 25], we next checked the effect of glucocorticoid hormones in lung and colon cancer cell lines and obtained the similar result that cortisol and cortisone inhibited Taxol-induced cell death as dose-dependent manner (Figure 1C and Supplementary Figu…”
Altered stress hormone response following acute exercise during prostate cancer treatment
Hanson, E. D., Sakkal, S., Evans, W. S., Violet, J. A., Battaglini, C. L., McConell, G. K., & Hayes, A. (2018) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13199 · Cited by 19
Rahman, M. R., Islam, T., Al-Mamun, M. A., Zaman, T., Karim, M. R., & Moni, M. A. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.100207 · Cited by 18
Exercise as a Potential Intervention to Modulate Cancer Outcomes in Children and Adults?
Kesting, S., Weeber, P., Schönfelder, M., Renz, B. W., Wackerhage, H., & von Luettichau, I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00196 · Cited by 19
“This finding is in line with other basic and clinical studies that report an association between β-blocker medication and better survival in ovarian cancer in mouse models (69, 70).”
ResultZhou, Q., Ding, W., Qian, Z., Jiang, G., Sun, C., & Ke Cheng, X. U. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s288983 · Cited by 16
Tiwari, R. K., Rawat, S. G., Gupta, V. K., Jaiswara, P. K., Sonker, P., Kumar, S., Gautam, V., Mishra, M. K., & Kumar, A. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110278 · Cited by 17
Li, Z., Huo, X., Zhang, S., Lü, J., Li, C., Guo, M., Fu, R., He, Z., Du, X., & Chen, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127355 · Cited by 16
“identified the β-adrenergic activation of the cAMP—PKA signaling pathway as one of the mechanisms that enhances tumor angiogenesis in vivo [32].”
BackgroundPsychological aspect of cancer: From stressor to cancer progression
YUAN, A., Wang, S., Li, Z., & Huang, C. (2009) · Experimental and Therapeutic Medicine · doi:10.3892/etm_00000003 · Cited by 16
Tan, X., Fujiu, K., Manabe, I., Nishida, J., Yamagishi, R., Terashima, Y., Matsushima, K., Kaburaki, T., Nagai, R., & Yanagi, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160985 · Cited by 19
“Sympathetic nervous system stimulation associated with stress has been shown to promote angiogenesis in a mouse model of ovarian carcinoma [42].”
BackgroundThe sympathetic nervous system shapes the tumor microenvironment to impair chemotherapy response
Manoleras, A. V., Sloan, E. K., & Chang, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1460493 · Cited by 15
Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response
Sud, S., O’Callaghan, C., Jonker, C., Karapetis, C. S., Price, T. J., Tebbutt, N. C., Shapiro, J. D., van Hazel, G., Pavlakis, N., Gibbs, P., et al. (2018) · Current Oncology · doi:10.3747/co.25.4069 · Cited by 15
Antitumor Anesthetic Strategy in the Perioperatory Period of the Oncological Patient: A Review
Ballestín, S. S., Bardaji, A. L., Continente, C. M., & Bartolomé, M. J. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.799355 · Cited by 19
GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases
Dwivedi, N. V., Datta, S., El‐Kersh, K., Sadikot, R. T., Ganti, A. K., Batra, S. K., & Jain, M. (2023) · The FASEB Journal · doi:10.1096/fj.202301091 · Cited by 17
Jiang, Y., Xu, J., Tao, C., Lin, Y., Lin, X., Li, K., Liu, Q., Saiyin, H., Hu, S., Yao, G., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1177061 · Cited by 18
“We used a restraint stress procedure as reported previously (5).”
BackgroundMethodSelf-citationChronic stress, sympathetic activation and skeletal metastasis of breast cancer cells
Elefteriou, F. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.61 · Cited by 20
“It is still unclear whether these direct effects of catecholamines on primary tumor cells have any repercussion on their ability to disseminate to secondary sites, although studies on prostate and ovarian cancer support a role for the b2AR and b3AR in tumor development and dissemination to distant organs.(42,53) It is…”
Backgroundβ-adrenergic-blocking drugs and melanoma: current state of the art
GIORGI, V. D., Grazzini, M., Gandini, S., Benemei, S., Asbury, C. D., Marchionni, N., & Geppetti, P. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.118 · Cited by 15
Le, C. P., Karnezis, T., Achen, M. G., Stacker, S. A., & Sloan, E. K. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.008 · Cited by 16
“Neural signalling through betaadrenergic pathways was recently identified as a physiological regulator of angiogenesis and metastasis [20, 24].”
InfluentialChoucair‐Jaafar, N., Beetz, N., Gilsbach, R., Yalçın, İ., Waltisperger, E., Freund‐Mercier, M. J., Monassier, L., Hein, L., & Barrot, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.015 · Cited by 15
“The time constant of left ventricular isovolumetric relaxation tau (s) was derived from left ventricular tracing, assuming a monoexponential decay of left ventricular pressure to a zero asymptote, and calculated applying the Weiss’ formula (Weiss et al., 1976; Basu et al., 2009).”
Wu, Y., Zhao, Y. Q., Ma, X., Zhu, Y., Patel, J., & Nie, Z. (2013) · Biochemical Journal · doi:10.1042/bj20121004 · Cited by 19
The Relationship Between Job Stress and Urinary Cytokines in Healthy Nurses: A Cross-Sectional Study
Fukuda, H., Ichinose, T., KUSAMA, T., Yoshidome, A., Anndow, K., Akiyoshi, N., & Shibamoto, T. (2008) · Biological Research For Nursing · doi:10.1177/1099800408323219 · Cited by 15
“Job-related stress in nurses not only decreases the quality of patient care, but also increases the risk of health problems in nurses, such as coronary heart disease (CHD) and depression (Lee, Colditz, Berkman, & Kawachi, 2004; McVicar, 2003).”
BackgroundInfluentialNew challenges in psycho‐oncology: Neural regulation of the cancer genome
Cole, S. W. (2018) · Psycho-Oncology · doi:10.1002/pon.4838 · Cited by 15
Self-citationCardiovascular Magnetic Resonance Imaging in Small Animals
Botnar, R. M., & Makowski, M. R. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00008-1 · Cited by 16
Xie, H., Li, B., Li, L., Zou, X., Zhu, C., Li, Y., Gao, N., Chen, Q., & Li, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099179 · Cited by 15
“A key component of the stress response involves activation of the sympathetic nervous system (SNS) and production of mediators which arise both from the SNS and the adrenal medulla [5].”
BackgroundInfluentialSelf-citationAssociation Between the Use of β-Adrenergic Receptor Agents and the Development of Venous Leg Ulcers
Margolis, D. J., Hoffstad, O., & Isseroff, R. R. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.10.1275 · Cited by 16
Adrenergic blockers and the risk for common solid cancers: a case–control study
Numbere, B., Fleming, K. M., Walker, A. J., & Card, T. R. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000218 · Cited by 15
“In addition, several preclinical studies propose that downstream β-adrenergic effects are mediated mainly by the β2 or β3 adrenergic receptors (Laag et al., 2006; Thaker et al., 2006).”
BackgroundThe β2‐Adrenoceptor Agonist Terbutaline Stimulates Angiogenesis via Akt and ERK Signaling
Lemmens, S., Kusters, L., Bronckaers, A., Geurts, N., & Hendrix, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25483 · Cited by 15
Neurotransmitters in tumors: chemical cross-talk shaping tumor progression
Chen, W., Yu, J., Ge, S., Yuan, T., Ding, X., Yan, B., Ye, L., Wang, Y., & Jia, R. (2025) · Biomarker Research · doi:10.1186/s40364-025-00835-6 · Cited by 22
“Additionally, the cAMP-PKA signaling pathway activated by chronic stress through the β2-AR represents another potential mechanism [98].”
Koçak, M. Z., Er, M. M., Uğraklı, M., Hendem, E., Araz, M., Eryılmaz, M. K., & Artaç, M. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03464-w · Cited by 14
“Adrenergic stimulation increases VEGF production by activating the protein kinase A signaling pathway [10].”
BackgroundChallenges for Preclinical Investigations of Human Biofield Modalities
Gronowicz, G., Bengston, W. F., & Yount, G. L. (2015) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2015.013.suppl · Cited by 14
Seiler, A., Sood, A. K., Jenewein, J., & Fagundes, C. P. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.013 · Cited by 16
Self-citationZhou, X., Liu, M., Deng, G., Chen, L., Sun, L., Zhang, Y., Luo, C., & Tang, J. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.03.001 · Cited by 14
“In mice models of ovarian carcinoma, the stress-induced release of catecholamines can activate the neuroendocrine system, leading to increased expression of VEGF, interleukin (IL)-6, and matrix metalloproteinase, which promote angiogenesis processes and more aggressive growth of EOC cells.(3,9) Based on above the evid…”
BackgroundMethodLam, T., Mastos, C., Sloan, E. K., & Halls, M. L. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108331 · Cited by 15
ß-Adrenoreceptors in Human Cancers
Krabóth, Z., & Kálmán, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043671 · Cited by 14
Guo, L., Du, Y., & Wang, J. (2015) · Scientific Reports · doi:10.1038/srep12939 · Cited by 14
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
Dickerson, E. B., & Bryan, B. A. (2015) · Veterinary Sciences · doi:10.3390/vetsci2030270 · Cited by 22
Gastrin-releasing peptide links stressor to cancer progression
Li, X., Lv, Y.-F., Yuan, A., & Li, Z. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0766-2 · Cited by 19
“cancer patients who received greater social support had lower levels of vascular endothelial growth factor (VEGF) than those who were greatly distressed (Thaker et al. 2006).”
BackgroundProteomic analysis of chronic restraint stress-induced Gan (肝)-stagnancy syndrome in rats
Sun, X., Zhong, X., Liu, Z., Cai, H., Fan, Q., Wang, Q., Liu, Q., Song, Y., He, S., Zhang, X.-F., et al. (2010) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-010-0525-z · Cited by 14
Pirl, W. F., Traeger, L. N., Greer, J. A., Bemis, H., Gallagher, E. R., Lennes, I. T., Sequist, L. V. D., Heist, R. S., & Temel, J. S. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0116 · Cited by 14
Targeted Systemic Delivery of Therapeutic siRNA
Gujrati, M. D., & Lu, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00004-4 · Cited by 15
Calvani, M., Subbiani, A., Bruno, G., & Favre, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7534693 · Cited by 14
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1
Hassan, S., Pullikuth, A., Nelson, K. C., Flores, A., Karpova, Y., Baiz, D., Zhu, S., Sui, G., Huang, Y., Choi, Y. A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1037 · Cited by 15
Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats
Benjamin, B., Hazut, O., Shaashua, L., Benish, M., Zmora, N., Barshack, I., Hoffman, A., Ben‐Eliyahu, S., & Zmora, O. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-0992-8 · Cited by 14
Nuclear factor-kappa B links carcinogenic and chemopreventive agents
Ralhan, R. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e6 · Cited by 24
“factors, NF-κB is perhaps most closely linked to transformation, proliferation, invasion, angiogenesis, and metastasis of tumors (31).”
Stone, S., McPherson, J. P., Kulkarni, R. P., & Young, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00890-z · Cited by 15
“Preclinical studies have demonstrated that stress can drive tumorigenesis 231,232 , progression 233 and metastasis 218,234 through activation of the sympathetic nervous system or hypothalamic–pituitary– adrenal axis, leading to upregulation of β-adrenergic 205,216,235 and glucocorticoid 236…”
Dopamine promotes the progression of AML via activating NLRP3 inflammasome and IL-1β
Wang, H., Zhang, C., Liu, J., Yang, X., Han, F., Wang, R., Zhao, H., Hou, M., & Ma, D. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.07.005 · Cited by 13
Benefits of β-blockers in cancer treatment
Arif, M., Hardianti, M. S., Tyagita, N., & Safitri, A. H. (2022) · Oncology in Clinical Practice · doi:10.5603/ocp.2022.0016 · Cited by 13
A health equity framework to support the next generation of cancer population simulation models
Chapman, C. H., Jayasekera, J. C., Dash, C., Sheppard, V. B., & Mandelblatt, J. S. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad017 · Cited by 14
Wang, B., Xu, Z., Sunthamala, N., Yaguchi, T., Huang, J., Kawakami, Y., Gong, Y., Tang, H., Li, S., Guo, Y., et al. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2738 · Cited by 13
“in animals has also been shown experimentally to worsen disease including prostate, ovarian, breast, and pancreatic cancer (28-32).”
BackgroundStress Hormones: Emerging Targets in Gynecological Cancers
Chen, G.-Q., Qiu, L., Gao, J., Wang, J., Dang, J., Li, L., Jin, Z., & Liu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699487 · Cited by 15
Is Infantile Hemangioma a Neuroendocrine Tumor?
Kaulanjan‐Checkmodine, P., Ouchérif, S., Prey, S., Gontier, É., Lacomme, S., Loot, M., Miljkovic‐Licina, M., Cario, M., Léauté-Labrèze, C., Taïeb, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095140 · Cited by 13
“showed that ADRB2 activation in ovarian carcinoma cell lines via the extrinsic stress-induced release of catecholamines results in the upregulation of VEGF, which in turn promotes tumor vascularization and aggressive growth [36].”
BackgroundLiu, B.-P., Zhang, C., Zhang, Y., Li, K.-W., & Song, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277945 · Cited by 14
Repurposing Drugs in Small Animal Oncology
Giuliano, A., Horta, R. D. S., Vieira, R. A. D. M., Hume, K. R., & Dobson, J. M. (2022) · Animals · doi:10.3390/ani13010139 · Cited by 15
Beloeil, H., & Nouette‐Gaulain, K. (2012) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2012.01.037 · Cited by 13
In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs
Röck, R., Bachmann, V. A., Bhang, H.-E. C., Malleshaiah, M. K., Raffeiner, P., Mayrhofer, J. E., Tschaikner, P., Bister, K., Aanstad, P., Pomper, M. G., et al. (2015) · Scientific Reports · doi:10.1038/srep11133 · Cited by 13
Sympathectomized tumor-bearing mice survive longer but develop bigger melanomas
Horváthová, Ľ., Tillinger, A., Padová, A., & Mravec, B. (2016) · Endocrine Regulations · doi:10.1515/enr-2016-0022 · Cited by 13
“…the tumor cell invasiveness and metastatic activity, support the neoangiogenesis in the tumor tissue, or suppress the natural killer cell activity (Godbout and Glaser 2006; Sood et al. 2006; Th aker et al. 2006; Andersen et al. 2007; Sephton et al. 2009; Hassan et al. 2013; Nagaraja et al. 2013).”
BackgroundEffect of long-term yoga practice on psychological outcomes in breast cancer survivors
Amritanshu, R., Rao, R. M., Raghuram, N., Veldore, V. H., Rani, U. U., Gopinath, K. S., & Ajaikumar, B. (2017) · Indian Journal of Palliative Care · doi:10.4103/ijpc.ijpc_93_17 · Cited by 16
“Indian Journal of Palliative Care ¦ Volume 23 ¦ Issue 3 ¦ July-September 2017 232 promote malignant cell growth.[9] Furthermore, in humans, psychological stress has shown to enhance carcinogenesis and cancer progression.”
BackgroundHe, J., Han, P., Zhang, Y., Liu, Y., Song, S., Feng, G., An, Y., Zhou, A., Wang, H., Li, Y., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1618-1 · Cited by 13
Self-citationThe prognostic value of ADRA1 subfamily genes in gastric carcinoma
Wang, T., Qin, Y., Lai, H., Wei, W., Li, Z., Yang, Y., Huang, M., & Chen, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10660 · Cited by 13
“furthermore, the tumour stromal cells in the microenvironment of cancer may be affected by the nervous system (28).”
BackgroundHazut, O., Shaashua, L., Benish, M., Levi, B., Sorski, L., Benjamin, B., Hoffman, A., Zmora, O., & Ben‐Eliyahu, S. (2011) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201550 · Cited by 13
VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors
Vilardi, B. M. R., Bravo-Calderón, D. M., Bernabé, D. G., Oliveira, S. H. P., & Oliveira, D. T. (2012) · Tumor Biology · doi:10.1007/s13277-012-0521-1 · Cited by 13
“Interestingly, some investigations have shown that norepinephrine may facilitate tumor progression by upregulation of vascular endothelial growth factor (VEGF) expression in malignant tumors of the nasopharynx [8], ovaries [9], pancreas Bruna Maria Rodrigues Vilardi and Daniel Galera Bernabé contributed equally to thi…”
BackgroundWang, L. P., Jin, J., Lv, F., Cao, J., Zhang, J., Wang, B.-Y., Shao, Z.-M., Hu, X., & Wang, Z. (2015) · PubMed · Cited by 13
The Interaction of TXNIP and AFq1 Genes Increases the Susceptibility of Schizophrenia
Su, Y., Ding, W., Xing, M., Qi, D., Li, Z., & Cui, D. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9954-7 · Cited by 13
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.